The Edit logo

The Edit Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.3/10

Best for: flat per-dose pricing from a brand that names its pharmacy and prescribing practice

7.3
★★★★☆3.7/5

The Edit scores highest on state availability and ease of access.

$109first month

then $209/mo ongoing

Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

The Edit is a clinician-led telehealth brand from The Edit Health LLC, a Texas management services organization based in Austin. It sells compounded semaglutide and tirzepatide for weight loss alongside NAD+, sermorelin, glutathione and GHK-Cu protocols. Prescribing is handled by an affiliated independent practice, Arora Health & Aesthetics, and prescriptions are dispensed by named partner pharmacy The Pharmacy Hub in Miami. Prices are published openly on every treatment page, there is no card on file to begin, and the site runs in both English and Spanish.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
LegitScript VerifiedFlat price at every doseNames its pharmacyFull refund if not approved2-day cold-chain shippingNo membership feeEnglish and Spanish site

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to The Edit

7.9/ 10
Verified partner

Trimi Health

Best for: budget-conscious shoppers

★★★★☆4/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →
8.0/ 10
Verified partner

ShedRx

Best for: mainstream telehealth GLP-1 access

★★★★☆4/5

Editorial score · methodology

$149/mo
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →
8.1/ 10
Verified partner

bmiMD

Best for: mainstream telehealth GLP-1 access

★★★★☆4.1/5

Editorial score · methodology

$99/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →
The Edit logo
3.7 / 5
Our editorial rating
Visit The Edit →

from $109/mo · no insurance needed

The Edit at a glance

Type
GLP-1 telehealth provider
Starting price
$109/mo ($109 first order via an automatically applied $100-off promotion, then $209/month. Prepay tiers are billed once upfront: 3 months $575 ($192/mo), 6 months $1,065 ($178/mo).)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
Availability
All 50 states
FDA status
No FDA warning letter on record

How we scored The Edit

Each dimension is scored algorithmically from The Edit’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.9/10

At $209/mo, The Edit runs about 24% above the $169 median for GLP-1 providers, and the first-month promo drops to $109. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.8/10

The Edit offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

7.5/10

Online intake and platform experience — app/portal-based, consult included in the price; 7 platform features disclosed.

Trust & Safety15%

7.5/10

Core details confirmed by our editors; no FDA warning letters on file; discloses which pharmacy makes its medication (last checked 2026-08-07).

Accessibility10%

8.0/10

The Edit treats patients in all 50 states.

Support10%

5.6/10

The Edit provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
573providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this The Edit review

Last checked August 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed availability in all 50 states
  • Confirmed what the monthly price does and doesn't include
  • Verified the compounding pharmacy partner and its accreditation
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What to expect when you sign up with The Edit

We walked The Edit’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Browse protocols on the public products page, where every price is shown before any account is created
  2. 2Start a visit and complete a HIPAA-compliant clinical intake, with no charge and no card on file to begin
  3. 3A licensed provider in your state reviews the intake and issues a prescription only if appropriate
  4. 4Medication is dispensed by a licensed compounding pharmacy and ships in unmarked, temperature-controlled 2-day packaging
  5. 5Ongoing care runs through automated refills, secure chat and a six-month clinical re-evaluation
Price shown before you start
  • Every treatment price is published on the public products page and on each treatment page, with no gate.
  • The site states plainly that getting started is free with no card on file, and that you are not charged if a protocol is not the right fit.
  • The $109 and $209 first-order figures are labelled as a limited-time promotion, with the standing rate shown next to them rather than hidden.
  • Prepay tiers are disclosed as billed once at the start of the plan, which is clearer than the per-month framing many competitors use.
  • The full legal suite is published and dated, including separate cancellation, refund and shipping policies.

GLP-1 medications The Edit offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

SemaglutideTirzepatideWegovyOzempicMounjaroZepboundRybelsus

Peptides The Edit offers

Beyond GLP-1s, The Edit also offers these peptides — tap any for our evidence-based guide.

DropletNAD+Cellular energy & longevitySyringeSermorelinGrowth-hormone supportDropletGlutathioneAntioxidant & detox supportLeafGHK-CuSkin, hair & tissue repair

Pricing

Prices re-verified

Month-to-month, same price at every doseCompounded
$209$109/mo
Save 48% right now
semaglutide

$109 first order via an automatically applied $100-off promotion, then $209/month. Prepay tiers are billed once upfront: 3 months $575 ($192/mo), 6 months $1,065 ($178/mo).

Month-to-month, same price at every doseCompounded
$309$209/mo
Save 32% right now
tirzepatide

$209 first order, then $309/month standing rate.

Ready to get started?

Plans and promotions change often — check The Edit's current pricing and active discounts before you decide.

See The Edit pricing →

The Edit compounding-pharmacy partners

Each partner below is a 503A or 503B pharmacy that The Edit routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.

The Pharmacy Hub

License footprint
1 states: FL
“Prescription products are dispensed by independent licensed pharmacies, including our partner pharmacy The Pharmacy Hub (15600 NW 15th Ave, Suite C, Miami, FL 33169; (888) 958-1382; thepharmacyhub.com)”

Source: theedithealth.com · Verified 2026-08-07

Compare every compounding pharmacy we’ve reviewed →

What we like

  • Publishes a real LegitScript seal (ID 51177190) and names both its dispensing pharmacy and its prescribing medical practice.
  • Charges the same price at every dose, so titrating up does not raise the monthly cost.
  • Nothing is charged to start, with no card on file, and a full refund if a clinician decides treatment is not appropriate.
  • Prices are published on every treatment page rather than gated behind intake, in both English and Spanish.

Watch-outs

  • The $209/mo standing semaglutide rate sits above the market median; the $109 headline is a first-order promo, not the ongoing price.
  • The 3- and 6-month rates are billed once upfront ($575 and $1,065), not as a lower monthly charge.
  • Terms claim all 50 states but also say availability is verified during consultation and may vary, so coverage is not guaranteed.
  • Cancellation ends at the close of the current billing period and part-used periods are not pro-rated or refunded.

Is The Edit worth it? Our verdict

The Edit positions itself around one thing: flat per-dose pricing from a brand that names its pharmacy and prescribing practice. New patients start at $109 in month one, but the price settles at $209/month after that — so the headline is a trial offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.

The Edit rounds out its offering with LegitScript Verified, Flat price at every dose, and Names its pharmacy.

How much The Edit actually costs

  • Compounded semaglutide — $109 first month, then $209/month
  • Compounded tirzepatide — $209 first month, then $309/month

For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so The Edit's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.

For a direct comparison, Maximus runs semaglutide and tirzepatide from $199.99/month — worth pricing against The Edit before you commit.

Medications: what The Edit prescribes

The Edit prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.

Who The Edit is best for — and who should skip it

A good fit if you…

  • want the cheapest possible way to start a GLP-1 and see how you respond before committing.
  • live anywhere in the US and want guaranteed access.

Look elsewhere if you…

  • want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
  • specifically want an FDA-approved brand-name pen.
  • need to bill insurance — like most of this market, it's cash-pay.

Trust, safety, and medical oversight

The Edit treats patients in all 50 states, and names the pharmacy that fills its prescriptions. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

The Edit is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $109 intro price steps up to $209/month. Use the first month to confirm the medication works for you, then re-check the ongoing math before you settle in.

The Bottom Line

The Edit scores highest on state availability and ease of access.

Score: 7.3/10Best for: flat per-dose pricing from a brand that names its pharmacy and prescribing practiceFrom: $109/mo

Ready to start with The Edit?

Starting at $109/month. See current pricing and start your free consultation.

Visit The Edit →

The Edit might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider ShedRx.
See all alternatives to The Edit →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this The Edit review:

Sources & methodology — as of August 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See The Edit's current pricing

Plans start at $109/month. Start your free consultation to check eligibility and today's price.

Visit The Edit →